Teva Pharmaceutical Industries (TEVA) Free Cash Flow Growth (1y) (2010 - 2026)
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Free Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.97 Bn | 2.15 Bn | 134.35% |
| 2 | Viatris | 19.19 Bn | 18.30 Bn | 1.46 Bn | 97.24% |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | -89.49% |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | -185.16% |
| 5 | Bausch Health Companies | 2.36 Bn | 520.30 Mn | 2.10 Bn | 212.11% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | -25.33% |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn | 70.75% |
| 9 | Fennec Pharmaceuticals | 404.35 Mn | 363.10 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 134.35% |
| Mar 31, 2026 | 10.34% |
| Dec 31, 2025 | 127.80% |
| Sep 30, 2025 | -57.25% |
| Jun 30, 2025 | 2,083.33% |
| Mar 31, 2025 | 6.45% |
| Dec 31, 2024 | -58.12% |
| Sep 30, 2024 | 478.47% |
| Jun 30, 2024 | -97.07% |
| Mar 31, 2024 | 12.68% |
| Dec 31, 2023 | 28.16% |
| Sep 30, 2023 | -134.20% |
| Jun 30, 2023 | 5,225.00% |
| Mar 31, 2023 | -37.86% |
| Dec 31, 2022 | 174.26% |
| Sep 30, 2022 | 9.92% |
| Jun 30, 2022 | -103.81% |
| Mar 31, 2022 | 62.88% |
| Dec 31, 2021 | 95.48% |
| Sep 30, 2021 | 133.54% |